Preventive Medicine

Episodes 1-4 of 4

• • 

    

    Shelley Zieroth, MD

    Peer

  7

  

  RestartResume

  Worsening Heart Failure: The How, Why, and When of Novel Treatment Options

  RestartResume

  Worsening Heart Failure: The How, Why, and When of Novel Treatment Options

  0.25 credits

  Worsening Heart Failure: The How, Why, and When of Novel Treatment Options

  0.25 credits

• • 

    

    Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  9

  CME/CE Broadcast Replay

  

  RestartResume

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  RestartResume

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  1.00 credit

  Let’s Examine Collaborative Patient Management in ASCVD Risk Reduction

  1.00 credit

• • 

    

    Mark J. Alberts, MD

    Peer

  • 

    

    Matthew Jay Budoff, MD

    Peer

  • 

    

    Lawrence A. Leiter, MD

    Peer

  6

  

  RestartResume

  Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease

  RestartResume

  Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease

  0.75 credits

  Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease

  0.75 credits

• • 

    

    Josep Comin-Colet, MD, PhD

    Peer

  11

  

  RestartResume

  Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure

  RestartResume

  Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure

  0.25 credits

  Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure

  0.25 credits